Arkolith/Insider Trading/RNAZ/Form 4

Dudley Robert Michael

Chief Executive Officer, DirectorTranscode Therapeutics, Inc. (RNAZ) · full profile →Form 4 · filed Jun 22, 2023
Net Buying
Open-Market Buys
$49K
Open-Market Sells
$0
Net Open-Market Flow
$49K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2023Buy(P)12K$2.65$32K82K
Jun 20, 2023Buy(P)7K$2.55$17K70K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-073872) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML